0.5 ML SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.01 MG/ML Prefilled Syringe [Nuvaxovid 2026-2027]
RxNorm concept 2751669, branded drug (sbd). Prescribable name: Nuvaxovid 2026-2027 vaccine 0.5 ML Prefilled Syringe.
- RxCUI
- 2751669
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2751669 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Nuvaxovid 2026-2027 vaccine 0.5 ML Prefilled Syringe
Related concepts
- SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.01 MG/ML (SCDC, consists of)
- SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.01 MG/ML [Nuvaxovid 2026-2027] (SBDC, consists of)
- Prefilled Syringe (DF, has dose form)
- Nuvaxovid 2026-2027 (BN, has ingredient)
- 0.5 ML SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.01 MG/ML Prefilled Syringe (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2751669 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2751669 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2751669. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.